4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0000950170-25-073746
Director acquired 5,144 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
GANNON STEVEN · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-05-14 | Exercise or conversion : show line 1 in the form | +5,144 | $12.57 | $64,660 | 7,144 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-05-14 | Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) | −5,144 | 0 | D |
Loading xslF345X05/ownership.xml…